---
figid: PMC9301130__fphar-13-910493-g002
figtitle: Effect of Lithocholic Acid on the Gut-Liver Axis
organisms:
- Saccharomyces cerevisiae
- Punica granatum
- Scutellaria baicalensis
- Rheum rhabarbarum
- Diospyros kaki
- Boswellia sacra
- Schisandra sphenanthera
- Swertia mussotii
- Lysimachia christinae
- Juniperus procera
- Escherichia coli
- Staphylococcus aureus
- Pseudomonas aeruginosa
- Helicobacter pylori
- Bacillus cereus
- Clostridium perfringens
- Clostridium scindens
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Danio rerio
- Xenopus laevis
- Macaca mulatta
- gut metagenome
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
- Macaca mulatta
- Xenopus laevis
pmcid: PMC9301130
filename: fphar-13-910493-g002.jpg
figlink: /pmc/articles/PMC9301130/figure/F2/
number: F2
caption: LCA mediated receptors and pathways. LCA mediates its functions through corresponding
  receptors. LCA activates VDR, and is involved in maintaining the function of TJs
  of intestinal epithelial cells and inhibition of Th1 cells. Natural ingredients
  can enhance VDR activation through LCA. Elevated LCA can activate TGR5, which promotes
  the secretion of GLP1 by intestinal epithelial cells, and participates in glucose
  metabolism and fat metabolism. The binding of LCA and PXR activates the transcription
  of FGF19. After recognition of FGFR4 on hepatocytes, it initiates the c-Jun N-terminal
  kinase (JNK) signaling pathway, which inhibits CYP7A1 and BA synthesis. In addition,
  activation of FXR induced by FXR agonist or some natural ingredients may change
  the composition of intestinal flora and promote the production of LCA. LCA, lithocholic
  acid; VDR, vitamin D receptor; TJs, tight junctions; TGR5, G protein-coupled receptor
  five; GLP1, glucagon-like peptide-1; PXR, pregnane X receptor; FGF19, fibroblast
  growth factor 19; FGFR4, FGF receptor four; CYP7A1, cholesterol 7α-hydroxylase.
papertitle: The Effect of Lithocholic Acid on the Gut-Liver Axis.
reftext: Wei Sheng, et al. Front Pharmacol. 2022;13:910493.
year: '2022'
doi: 10.3389/fphar.2022.910493
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: lithocholic acid | natural products | intestinal barrier | gut microbiota
  | bile acid receptors
automl_pathway: 0.9608557
figid_alias: PMC9301130__F2
figtype: Figure
redirect_from: /figures/PMC9301130__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9301130__fphar-13-910493-g002.html
  '@type': Dataset
  description: LCA mediated receptors and pathways. LCA mediates its functions through
    corresponding receptors. LCA activates VDR, and is involved in maintaining the
    function of TJs of intestinal epithelial cells and inhibition of Th1 cells. Natural
    ingredients can enhance VDR activation through LCA. Elevated LCA can activate
    TGR5, which promotes the secretion of GLP1 by intestinal epithelial cells, and
    participates in glucose metabolism and fat metabolism. The binding of LCA and
    PXR activates the transcription of FGF19. After recognition of FGFR4 on hepatocytes,
    it initiates the c-Jun N-terminal kinase (JNK) signaling pathway, which inhibits
    CYP7A1 and BA synthesis. In addition, activation of FXR induced by FXR agonist
    or some natural ingredients may change the composition of intestinal flora and
    promote the production of LCA. LCA, lithocholic acid; VDR, vitamin D receptor;
    TJs, tight junctions; TGR5, G protein-coupled receptor five; GLP1, glucagon-like
    peptide-1; PXR, pregnane X receptor; FGF19, fibroblast growth factor 19; FGFR4,
    FGF receptor four; CYP7A1, cholesterol 7α-hydroxylase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Bas
  - Tnf
  - Mapk8
  - Fgfr4
  - Nr1i2
  - Fgf15
  - Vdr
  - Cyp27b1
  - Th
  - Tbx21
  - Stat1
  - Stat4
  - Clta
  - Ptprc
  - Nr1h4
  - Gpbar1
  - Nfe2l2
  - Rela
  - Gorasp1
  - Nfkb1
  - Abcg1
  - Wdtc1
  - Creb1
  - Gcg
  - Lce1l
  - Atf2
  - BAS
  - TNF
  - MAPK8
  - MAPK9
  - MAPK10
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - NR1I2
  - FGF19
  - VDR
  - CYP27B1
  - TH
  - TBX21
  - STAT1
  - STAT4
  - CLTA
  - GUCY2D
  - PTPRC
  - NR1H4
  - GPBAR1
  - GABPA
  - NFE2L2
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - NFKB1
  - RELB
  - REL
  - NFKB2
  - NFKBIA
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - GCG
  - GLP1R
  - ZGLP1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - Fgf19
  - Syt1
  - Lce1e
  - tnfb
  - mapk8b
  - fgfr4
  - nr1i2
  - fgf19
  - vdra
  - th
  - stat1a
  - stat1b
  - stat4
  - tnfrsfa
  - fxr
  - nfe2l2a
  - rela
  - tnf.L
  - tnf.S
  - mapk8.L
  - mapk8.S
  - fgfr4.L
  - fgfr4.S
  - fgf19.L
  - fgf19.S
  - vdr.S
  - cyp27b1.L
  - cyp27b1.S
  - eomes.S
  - tbx21.L
  - stat1.L
  - clta.S
  - clta.L
  - nr1h5.S
  - nr1h4.L
  - nr1h4.S
  - gpbar1.S
  - gpbar1.L
  - gabpa.S
  - nfe2l2.L
  - nfe2l2.S
  - gabpa.L
  - rela.L
  - rela.S
  - nfkb1.L
  - nfkb1.S
  - creb1.S
  - creb1.L
  - prickle1.S
  - dlc.L
---
